BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30968591)

  • 21. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
    Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
    Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Alport syndrome diagnosis using next-generation sequencing.
    Artuso R; Fallerini C; Dosa L; Scionti F; Clementi M; Garosi G; Massella L; Epistolato MC; Mancini R; Mari F; Longo I; Ariani F; Renieri A; Bruttini M
    Eur J Hum Genet; 2012 Jan; 20(1):50-7. PubMed ID: 21897443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of digenic inheritance in Alport syndrome.
    Mencarelli MA; Heidet L; Storey H; van Geel M; Knebelmann B; Fallerini C; Miglietti N; Antonucci MF; Cetta F; Sayer JA; van den Wijngaard A; Yau S; Mari F; Bruttini M; Ariani F; Dahan K; Smeets B; Antignac C; Flinter F; Renieri A
    J Med Genet; 2015 Mar; 52(3):163-74. PubMed ID: 25575550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-collagen genes role in digenic Alport syndrome.
    Daga S; Fallerini C; Furini S; Pecoraro C; Scolari F; Ariani F; Bruttini M; Mencarelli MA; Mari F; Renieri A; Pinto AM
    BMC Nephrol; 2019 Feb; 20(1):70. PubMed ID: 30808327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.
    Hou P; Chen Y; Ding J; Li G; Zhang H
    Am J Nephrol; 2007; 27(5):538-44. PubMed ID: 17726307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 27 Novel Variants in Genes
    Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
    Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
    Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
    Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
    Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
    Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population.
    Webb BD; Brandt T; Liu L; Jalas C; Liao J; Fedick A; Linderman MD; Diaz GA; Kornreich R; Trachtman H; Mehta L; Edelmann L
    Clin Genet; 2014 Aug; 86(2):155-60. PubMed ID: 23927549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
    Storey H; Savige J; Sivakumar V; Abbs S; Flinter FA
    J Am Soc Nephrol; 2013 Dec; 24(12):1945-54. PubMed ID: 24052634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
    Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
    BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.
    Guo L; Li D; Dong S; Wan D; Yang B; Huang Y
    J Genet; 2017 Jun; 96(2):389-392. PubMed ID: 28674241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.
    Uzak AS; Tokgoz B; Dundar M; Tekin M
    Genet Test Mol Biomarkers; 2013 Mar; 17(3):260-4. PubMed ID: 23297803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence Estimates of Predicted Pathogenic
    Gibson J; Fieldhouse R; Chan MMY; Sadeghi-Alavijeh O; Burnett L; Izzi V; Persikov AV; Gale DP; Storey H; Savige J;
    J Am Soc Nephrol; 2021 Sep; 32(9):2273-2290. PubMed ID: 34400539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
    Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
    Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
    Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
    Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.